Perrigo Company plc is an American international manufacturer of private label over-the-counter pharmaceuticals. Perrigo engages in the manufacture and sale of consumer healthcare products, generic prescription drugs, active pharmaceutical ingredients (API), and consumer products through its wholly owned subsidiaries, primarily in the United States, Australia, Israel, Europe, India and Mexico. In March 2005 the firm acquired Agis Industries Ltd., an Israel-based generic pharmaceuticals company for $850 million.
Agis was founded by Moshe (Mori) Arkin in 1983. Arkin, who now owns 9% of Perrigo and was appointed as Vice Chairman of the company after the aquisition, developed his father's small drug import business into a multinational generic pharmaceutical company, changing the world of pharmaceutical. Today, Perrigo employs over 1,200 workers in Israel in three locations, including an R&D Center as well as manufacturing facilities, which are FDA-inspected, cGMP-compliant and recognized for environmental stewardship. Perrigo is planning to expand its facilities to other locations across Israel in the near future.